Metacel Drug Patent Portfolio
Metacel owns 1 orange book drug protected by 1 US patent Given below is the list of Metacel's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US10610502 | Oral baclofen solutions | 30 Aug, 2039 | Active |
Latest Legal Activities on Metacel's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Metacel.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Payment of Maintenance Fee, 4th Yr, Small Entity | 08 Nov, 2023 | US10610502 |
| Surcharge for late Payment, Small Entity | 08 Nov, 2023 | US10610502 |
|
Application ready for PDX access by participating foreign offices
Critical
| 07 Apr, 2020 | US10610502 |
|
Recordation of Patent Grant Mailed
Critical
| 07 Apr, 2020 | US10610502 |
|
Patent Issue Date Used in PTA Calculation
Critical
| 07 Apr, 2020 | US10610502 |
|
Email Notification
Critical
| 19 Mar, 2020 | US10610502 |
|
Issue Notification Mailed
Critical
| 18 Mar, 2020 | US10610502 |
| Printer Rush- No mailing | 16 Mar, 2020 | US10610502 |
|
Email Notification
Critical
| 16 Mar, 2020 | US10610502 |
|
Mail Response to 312 Amendment (PTO-271)
Critical
| 16 Mar, 2020 | US10610502 |
| Dispatch to FDC | 13 Mar, 2020 | US10610502 |
|
Application Is Considered Ready for Issue
Critical
| 12 Mar, 2020 | US10610502 |
|
Response to Amendment under Rule 312
Critical
| 12 Mar, 2020 | US10610502 |
|
Pubs Case Remand to TC
Critical
| 10 Mar, 2020 | US10610502 |
|
Issue Fee Payment Verified
Critical
| 26 Feb, 2020 | US10610502 |
Metacel's Family Patents
Metacel Drug List
Given below is the complete list of Metacel's drugs and the patents protecting them.
1. Ozobax
Ozobax is protected by 1 patent, which is still active. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US10610502 | Oral baclofen solutions |
30 Aug, 2039
(13 years from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Ozobax's drug page